First, patients have a biopsy. Then, the test measures which genes are in the tumor.
As many as half of all prostate cancers in the US are low-risk. About 100,000 of men in this category undergo treatment, even though there's only a three percent chance their disease will progress or become life threatening.
Copyright 2016 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.